“Sigma Antagonists for Treatment of Neuropathic Pain Syndromes in Cancer Patients: A Narrative Review”, J. Can. Res. Updates, vol. 11, pp. 70–77, Oct. 2022, doi: 10.30683/1929-2279.2022.11.10.